The expression level of TENT5B is downregulated in patients with prostate cancer, and overexpression of the TENT5B gene inhibits prostate cancer cell proliferation in vitro and tumor growth in vivo (Liang et al., 2018). Here, TENT5B is linked to neoplasm.